Withdrawal of Tiratricol Treatment in Males With Monocarboxylate Transporter 8 Deficiency (MCT8 Deficiency)

NCT05579327 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

20

Enrollment

INDUSTRY

Sponsor class

Conditions

Monocarboxylate Transporter 8 Deficiency
Allan-Herndon-Dudley Syndrome

Interventions

DRUG: Tiratricol
DRUG: Placebo

Sponsor

Rare Thyroid Therapeutics International AB

Collaborators

[object Object]
[object Object]